(Nano) platforms in bladder cancer therapy: Challenges and opportunities

M Ashrafizadeh, A Zarrabi… - Bioengineering & …, 2023 - Wiley Online Library
Urological cancers are among the most common malignancies around the world. In
particular, bladder cancer severely threatens human health due to its aggressive and …

[HTML][HTML] Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling

M Entezari, M Ghanbarirad, A Taheriazam… - Biomedicine & …, 2022 - Elsevier
Among the different kinds of tumors threatening human life, lung cancer is one that is
commonly observed in both males and females. The aggressive behavior of lung cancer …

Nanotechnological approaches in prostate cancer therapy: integration of engineering and biology

M Ashrafizadeh, S Aghamiri, SC Tan, A Zarrabi… - Nano Today, 2022 - Elsevier
Nanocarriers have received special attention in biomedicine for the treatment of various
diseases, especially cancer, as one of the leading causes of death worldwide. Nanocarriers …

NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition

S Mirzaei, S Saghari, F Bassiri, R Raesi… - Journal of cellular …, 2022 - Wiley Online Library
Metastasis of tumor cells is a complex challenge and significantly diminishes the overall
survival and prognosis of cancer patients. The epithelial‐to‐mesenchymal transition (EMT) …

Long noncoding RNAs (lncRNAs) in pancreatic cancer progression

M Ashrafizadeh, N Rabiee, AP Kumar, G Sethi… - Drug Discovery …, 2022 - Elsevier
Long noncoding RNAs (lncRNAs) are RNA molecules involved in gene regulation at
transcriptional, post-transcriptional, and epigenetic levels. LncRNAs participate in regulating …

Non-coding RNAs and macrophage interaction in tumor progression

M Entezari, M Sadrkhanloo, M Rashidi, SE Asnaf… - Critical reviews in …, 2022 - Elsevier
The macrophages are abundantly found in TME and their M2 polarization is in favor of tumor
malignancy. On the other hand, non-coding RNAs (ncRNAs) can modulate macrophage …

Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects

M Hashemi, S Mirzaei, M Barati, ES Hejazi… - Life sciences, 2022 - Elsevier
Urological cancers include bladder, prostate and renal cancers that can cause death in
males and females. Patients with urological cancers are mainly diagnosed at an advanced …

[HTML][HTML] Regulated cell death in urinary malignancies

Z Nie, M Chen, Y Gao, D Huang, H Cao… - Frontiers in Cell and …, 2021 - frontiersin.org
Urinary malignancies refer to a series of malignant tumors that occur in the urinary system
and mainly include kidney, bladder, and prostate cancers. Although local or systemic …

Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: mechanisms of initiation, progression, and drug sensitivity

MK Mahabady, S Mirzaei, H Saebfar… - Journal of Cellular …, 2022 - Wiley Online Library
The identification of agents that can reverse drug resistance in cancer chemotherapy, and
enhance the overall efficacy is of great interest. Paclitaxel (PTX) belongs to taxane family …

[HTML][HTML] Long noncoding RNA LINC02470 sponges MicroRNA-143-3p and enhances SMAD3-mediated epithelial-to-mesenchymal transition to promote the …

CS Huang, CH Tsai, CP Yu, YS Wu, MF Yee, JY Ho… - Cancers, 2022 - mdpi.com
Simple Summary Long noncoding RNAs (lncRNAs) were proposed as novel tumor
prognostic markers, including for predicting bladder cancer progression, and the competing …